Clinical Trials | April 22, 2026
Moderna launches late-stage trial of mRNA bird flu vaccine
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The Union Minister noted that heat stress contributes to a rise in both communicable diseases such as dengue and non-communicable conditions like cardiovascular disorder
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
